British firm's Korean unit apologises over poison deaths

Image
AFP Seoul
Last Updated : May 02 2016 | 7:58 PM IST
The head of a Korean subsidiary of a British consumer goods company was slapped and shouted down today as he apologised for his firm's role in selling a humidifier disinfectant blamed for more than 100 deaths in South Korea.
Shouting "too late" and "cannot forgive" in English, a handful of the victims' relatives rushed the podium where Ata Safdar, the head of Oxy Reckitt Benckiser Korea, was speaking at a hotel in Seoul.
The executive was slapped and pushed several times as the event descended into chaos.
"I'm sorry. I'm truly sorry. I deeply apologise. We want to make amends," Safdar told the angry relatives, bowing repeatedly in a gesture of contrition.
Safdar was finally able to resume his statement, in which he offered a "heartfelt and sincere apology" to all the victims and said his company was committed to a multi-million dollar compensation plan.
The case came to light after four pregnant women died of lung problems for unknown reasons in 2011.
A subsequent government probe found a "significant association" between lung damage and products used to sterilise domestic humidifiers.
Most of the victims were found to have used Oxy Ssak Ssak, a liquid humidifier disinfectant sold by Reckitt Benckiser in South Korea from 2001, that has been blamed for around 103 deaths -- mostly women and children.
The products were withdrawn from local markets in 2011.
"Oxy RB accepts responsibility for the role that Oxy RB products played and the delay in providing adequate remedy," Safdar said.
He also announced the creation of a five billion won (USD 4.3 million) humanitarian fund to "provide assistance to those who have suffered".
The company had earlier donated a similar amount to a fund set up by the South Korean Environment Ministry.
The company has been sharply criticised in South Korea for taking too long to apologise or accept any responsibility in the case.
Safdar said his office would cooperate fully with an ongoing probe into whether executives had approved the sale of toxic sterilisers while knowing of the health risks.
"My sincere hope is that the investigation is concluded as soon as possible, so we can help bring about closure for all affected victims," he said.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: May 02 2016 | 7:58 PM IST

Next Story